Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for July 2008
July 1, 2008
July 2, 2008
- Summary Judgment Granted for Seroquel Patent Litigation
- Publicis Groupe Acquires Kekst and Company, Incorporated World’s Premier Strategic and Financial Public Relations Firm
- Pfizer Changes Its Funding of Continuing Medical Education in the U.S.
July 3, 2008
- Shire to Add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
- Adolor Provides Update on Entereg (alvimopan) OBD Program
July 7, 2008
- APP Pharmaceuticals to Be Acquired by Fresenius
- Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share
- Introgen Reduces Development Staff to Focus on Commercial Activities after Advexin Regulatory Filings in U.S. and Europe
- Global Pharmaceutical Industry at a Crossroads
July 8, 2008
- Novartis Completes Purchase of Minority Interest in Alcon
- Giaconda Suspends Hepaconda Phase II Trial to Carry Out Dose Ranging
- Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments
- MediGene Puts Clinical Phase I Study with RhuDex On Hold
July 9, 2008
- Lilly to Acquire SGX Pharmaceuticals
- New Casa Report Finds: Most Web Sites Selling Prescription Opioids, Stimulants and Depressants Require No Prescription
- Solvay Pharmaceuticals S.A. Increases to Eur 6.50 Per Share Its Initial Tender Offer to Acquire Innogenetics
- Second Quarter Health Care M&A Strongest In Years According To New Report From Irving Levin Associates, Inc.
- FDA Revises Process for Responding to Drug Applications
- Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court
July 10, 2008
- Novartis Buys Additional 51.7% Stake in Speedel and Announces Plans to Acquire Remaining Shares in a Mandatory Public Tender Offer
- PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals
- Ratio-morphine Tablets Recalled in Canada Due to Risk of Accidental Overdose
- Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
- New Study Shows Physicians Use Numerous Sources to Inform Prescribing Decisions for Patients
- Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals
- Enlight Biosciences Launched in Collaboration with Merck & Co., Inc., Pfizer, and Eli Lilly
- Pharmaceutical Companies Spend More in Vermont in 2007, Says Attorney General Sorrell
- Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
- FDA MedWatch - Herceptin 440mg Vials & BWFI Diluent-Complaints of Damaged and Broken Vials That May Lead to a Loss of Sterility
- Templeton Asset Management Rejects Sun Pharmaceutical's Tender Offer for Taro Pharmaceutical
July 11, 2008
- Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug Application with a Paragraph IV Certification for Generic Version of Copaxone
- Richard F. Selden, Former CEO of a Massachusetts Biotechnology Company, Settles SEC Fraud Action
- Statement of the Coalition for Healthcare Communication On the Value of Independent Commercial Providers of CME
July 14, 2008
- Ranbaxy Issues Statement on DOJ Investigation of Drugs Sold in U.S.
- Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
- Ortho Biotech and Amgen Resolve Antitrust Litigation
- Neurogen Announces Suspension of Insomnia Study with Adipiplon
- FDA Updates Label for Avandia to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
- Actelion and GlaxoSmithKline Enter Into Exclusive Collaboration to Realise the Full Potential of Almorexant in Sleep Disorders and Beyond
- Two New Jersey Hormone Therapy Lawsuits Dismissed
- FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports of Microangiopathic Hemolytic Anemia In Patients Treated With This Combination
July 15, 2008
- Genentech Announces Second Quarter 2008 Results
- Company Suspended From ABPI Membership Over Breaches Of Code Of Practice
- Infinity Provides Update On Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer
- Jerini Receives European Commission Approval for Firazyr (Icatibant) in the Treatment of HAE
- MediGene Publishes Update on RhuDex Incident
July 16, 2008
- BioAlliance Pharma Suspends the Phase II/III Trial of Doxorubicin Transdrug in Primary Liver Cancer
- Global Market for Cancer Therapies Slated for High Growth Through 2013
- Bristol-Myers Squibb Agrees to Pay More Than $9 Million to Massachusetts Medicaid Program to Settle Allegations of Improper Marketing and Business Practices
- Procter & Gamble Announces Organizational Changes
- Concerned Shareholders of Biovail Pleased with Court Order for Biovail AGM
- SEC Charges Mayor of Beaufort, S.C., With Insider Trading in Stock of Biotech Company
- Concerned Shareholders Respond to Biovail's Press Release
July 17, 2008
- Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
- Daiichi Sankyo and Ranbaxy Confirm Deal is Binding and Final, Allay Market Rumour and Speculation
- Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit
- FDA Advisory Committee Provides Opinion of Doribax for the Treatment of Hospital-Acquired Pneumonia
- Novartis Gains Momentum with Strong Performance in First Half of 2008 from Portfolio Focused on Growth Areas of Healthcare
- Bellus Health Announces Closing of Innodia Acquisition
- New Report: Investment in Disease Prevention Could Save America More than $16 Billion in Five Years
- Statement: NIAID Will Not Move Forward with the Pave 100 HIV Vaccine Trial VRC
July 18, 2008
- Teva to Acquire Barr
- Gilead Sciences Announces Second Quarter 2008 Financial Results
- Zentiva Responds to Sanofi-Aventis CZK 1,050 per Share Voluntary Offer
July 21, 2008
- Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
- Roche Proposes to buy Full Stake in Genentech - Interview With Chairman
- Biota Holdings Limited (ASX:BTA) and GSK Conclude Litigation Through Mediation
- FDA Rule and Companion Guidance Make Early Stage Clinical Drug Development Safe and Efficient
- Roche Posts Very Good Results: Strong Market Outperformance – Guidance Confirmed
- Genentech Announces Receipt of Proposal From Roche
- Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
July 22, 2008
- Schering-Plough Reports Financial Results for Second Quarter of 2008
- Forest Laboratories, Inc. Reports Fiscal First Quarter 2009 Earnings Per Share of $0.79, Including $0.08 per Share Charge for Agreement Termination
- Roche Acquires Mirus to Advance Research in the Field of RNAi Delivery
- Biogen Idec Reports Second Quarter 2008 Results
- Merck Reports Second-Quarter 2008 Financial Results
July 23, 2008
- Roche Starts Acquisition Process of Arius to Gain Access to New Screening Platform for Antibody Therapeutics
- Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance
- Pfizer Reports Second-Quarter 2008 Results
- Progen Terminates Pathway Trial & Confirms Focus on Potential High Value Molecules and M&A
- Dingell, Stupak to Investigate Ranbaxy Drug Approvals
- GSK Sets Out New Strategic Priorities
- Dan Troy Appointed as Senior Vice President and General Counsel for GlaxoSmithKline
- GSK Enters Transformational Agreement with Aspen to Drive Growth in Emerging Markets
- Erythropoietins: The Shift from Biosimilars to "more for less" ESAs
July 24, 2008
- Alcon's Second Quarter Sales Rise 17.9 Percent; Net Earnings Increase 26.3 Percent
- Lilly Reports Solid Second-Quarter Results
- Bristol-Myers Squibb Continues Strong Financial Performance Led by Double-Digit Global Sales Growth
- Pharmacopeia Advances Therapeutic Program with GlaxoSmithKline
- Cohen Milstein Hausfeld & Toll P.L.L.C. Files Lawsuit Concerning Genentech Buyout
- Solvay Pharmaceuticals S.A. Plans the Offer Period for Innogenetics from August 12 to September 5, 2008
- Biogenerics Would Reduce Health Care Costs for Patients, Says GPhA High Health Care Costs the Focus of Joint Economic Committee Hearing
July 25, 2008
- Genentech Forms Special Committee of Independent Directors to Review Roche Proposal
- With Drug Company Profits Soaring, Sen. Brown Renews Investigation of Drug Industry Outsourcing to China
- Recommended Cash Offer for Acambis Plc by Sanofi Pasteur Holding
July 28, 2008
July 29, 2008
- Amgen's Second Quarter 2008 Adjusted Earnings Per Share Increased 2 Percent to $1.14
- Mylan Acquires Remaining Interest in Somerset Joint Venture From Watson
- Harris Poll: Number of "Cyberchondriacs" - Adults Going Online for Health Information - Has Plateaued or Declined
- Acusphere Announces Staff Reductions
- Statins May Protect Against Memory Loss
- Schweizerhall: Clopidogrel in Germany – Court Orders Immediate Execution of Approval
- SDI Acquires Verispan
July 30, 2008
- Clopidogrel in Germany
- Bayer Continues Its Success
- FDA Sends Letter to Baxter Over 'Clinical Thank You Email'
July 31, 2008
- FDA Issues Complete Response Letters Ordering Safety Labeling Changes Under FDAAA for Aranesp, Epogen, and Procrit
- Amgen Issues Statement in Response to Revised ESA Labeling Received from the FDA Today
- Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
- Sanofi-aventis News
- Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade
- AstraZeneca PLC Second Quarter and Half Year Results
- Photos: Bayer Names New U.S. CEO
